These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 33431966)

  • 1. Opioid use may be associated with postoperative complications in myotonic dystrophy type 1 with high-grade muscular impairment.
    Kim CS; Park JM; Park D; Kim DH; Park JS
    Sci Rep; 2021 Jan; 11(1):8. PubMed ID: 33431966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for perioperative adverse events in children with myotonic dystrophy.
    Sinclair JL; Reed PW
    Paediatr Anaesth; 2009 Aug; 19(8):740-7. PubMed ID: 19624361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional impairment in patients with myotonic dystrophy type 1 can be assessed by an ataxia rating scale (SARA).
    DiPaolo G; Jimenez-Moreno C; Nikolenko N; Atalaia A; Monckton DG; Guglieri M; Lochmüller H
    J Neurol; 2017 Apr; 264(4):701-708. PubMed ID: 28168524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of a disease-specific muscular impairment rating scale in myotonic dystrophy.
    Mathieu J; Boivin H; Meunier D; Gaudreault M; Bégin P
    Neurology; 2001 Feb; 56(3):336-40. PubMed ID: 11171898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five-year study of quality of life in myotonic dystrophy.
    Peric S; Vujnic M; Dobricic V; Marjanovic A; Basta I; Novakovic I; Lavrnic D; Rakocevic-Stojanovic V
    Acta Neurol Scand; 2016 Nov; 134(5):346-351. PubMed ID: 27696366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organ dysfunction and muscular disability in myotonic dystrophy type 1.
    Kaminsky P; Poussel M; Pruna L; Deibener J; Chenuel B; Brembilla-Perrot B
    Medicine (Baltimore); 2011 Jul; 90(4):262-268. PubMed ID: 21694643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myotonic dystrophy type 1: A comparison between the adult- and late-onset subtype.
    Joosten IBT; Horlings CGC; Vosse BAH; Wagner A; Bovenkerk DSH; Evertz R; Vernooy K; van Engelen BGM; Faber CG
    Muscle Nerve; 2023 Feb; 67(2):130-137. PubMed ID: 36484161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of respiratory muscle involvement in myotonic dystrophy type 1.
    Henke C; Spiesshoefer J; Kabitz HJ; Herkenrath S; Randerath W; Brix T; Görlich D; Young P; Boentert M
    Neuromuscul Disord; 2020 Jan; 30(1):17-27. PubMed ID: 31839403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Postoperative continuous epidural infusion of morphine in a patient with myotonic dystrophy].
    Takeda T; Tohmatsu T; Harada T; Murakami N; Dohi S
    Masui; 1996 Nov; 45(11):1384-7. PubMed ID: 8953873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benign tumors in myotonic dystrophy type I target disease-related cancer sites.
    Alsaggaf R; St George DMM; Zhan M; Pfeiffer RM; Wang Y; Anderson LA; Liu Z; Koshiol J; Bauer AJ; Wagner KR; Greene MH; Amr S; Gadalla SM
    Ann Clin Transl Neurol; 2019 Aug; 6(8):1510-1518. PubMed ID: 31402615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical use of bioelectrical impedance analysis in patients affected by myotonic dystrophy type 1: A cross-sectional study.
    Rinninella E; Silvestri G; Cintoni M; Perna A; Martorana GE; De Lorenzo A; Rossini PM; Miggiano GAD; Gasbarrini A; Mele MC
    Nutrition; 2019; 67-68():110546. PubMed ID: 31376676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consensus-Based Care Recommendations for Pulmonologists Treating Adults with Myotonic Dystrophy Type 1.
    Boentert M; Cao M; Mass D; De Mattia E; Falcier E; Goncalves M; Holland V; Katz SL; Orlikowski D; Sannicolò G; Wijkstra P; Hellerstein L; Sansone VA
    Respiration; 2020; 99(4):360-368. PubMed ID: 32299079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Muscular disability and organ impairments in myotonic dystrophy type 1].
    Pruna L; Machado F; Louis L; Vassé G; Kaminsky P
    Rev Neurol (Paris); 2011 Jan; 167(1):23-8. PubMed ID: 20934732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatigue in myotonic dystrophy type 1: a seven-year prospective study.
    Peric S; Bjelica B; Bozovic I; Pesovic J; Paunic T; Banovic M; Brkusanin M; Aleksic K; Basta I; Pavicevic DS; Stojanovic VR
    Acta Myol; 2019 Dec; 38(4):239-244. PubMed ID: 31970322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A model to predict ventilator requirement in myotonic dystrophy type 1.
    Vivekananda U; Turner C
    Muscle Nerve; 2019 Jun; 59(6):683-687. PubMed ID: 30895625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and predictor factors of respiratory impairment in a large cohort of patients with Myotonic Dystrophy type 1 (DM1): A retrospective, cross sectional study.
    Rossi S; Della Marca G; Ricci M; Perna A; Nicoletti TF; Brunetti V; Meleo E; Calvello M; Petrucci A; Antonini G; Bucci E; Licchelli L; Sancricca C; Massa R; Rastelli E; Botta A; Di Muzio A; Romano S; Garibaldi M; Silvestri G
    J Neurol Sci; 2019 Apr; 399():118-124. PubMed ID: 30798109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excessive daytime somnolence and increased rapid eye movement pressure in myotonic dystrophy.
    Gibbs JW; Ciafaloni E; Radtke RA
    Sleep; 2002 Sep; 25(6):662-5. PubMed ID: 12224846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anesthetic and surgical complications in 219 cases of myotonic dystrophy.
    Mathieu J; Allard P; Gobeil G; Girard M; De Braekeleer M; Bégin P
    Neurology; 1997 Dec; 49(6):1646-50. PubMed ID: 9409361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myotonic dystrophies type 1 and 2: anesthetic care.
    Veyckemans F; Scholtes JL
    Paediatr Anaesth; 2013 Sep; 23(9):794-803. PubMed ID: 23384336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A large multicenter study of pediatric myotonic dystrophy type 1 for evidence-based management.
    Lagrue E; Dogan C; De Antonio M; Audic F; Bach N; Barnerias C; Bellance R; Cances C; Chabrol B; Cuisset JM; Desguerre I; Durigneux J; Espil C; Fradin M; Héron D; Isapof A; Jacquin-Piques A; Journel H; Laroche-Raynaud C; Laugel V; Magot A; Manel V; Mayer M; Péréon Y; Perrier-Boeswillald J; Peudenier S; Quijano-Roy S; Ragot-Mandry S; Richelme C; Rivier F; Sabouraud P; Sarret C; Testard H; Vanhulle C; Walther-Louvier U; Gherardi R; Hamroun D; Bassez G
    Neurology; 2019 Feb; 92(8):e852-e865. PubMed ID: 30659139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.